Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Net Issuance of Debt
Abbott Laboratories
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Debt
$-2.5B
|
CAGR 3-Years
-267%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Issuance of Debt
$-560m
|
CAGR 3-Years
34%
|
CAGR 5-Years
19%
|
CAGR 10-Years
-11%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Debt
$-4m
|
CAGR 3-Years
84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Issuance of Debt
$-300k
|
CAGR 3-Years
28%
|
CAGR 5-Years
77%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Debt
$-277m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott Laboratories's Net Issuance of Debt?
Net Issuance of Debt
-2.5B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Net Issuance of Debt amounts to -2.5B USD.
What is Abbott Laboratories's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
22%
Over the last year, the Net Issuance of Debt growth was -254%. The average annual Net Issuance of Debt growth rates for Abbott Laboratories have been -267% over the past three years , 22% over the past five years .